Literature DB >> 24489570

Evaluation of MRSASelect (™) chromogenic medium for the early detection of methicillin-resistant Staphylococcus aureus from blood cultures.

Kanchana Manickam1, Andrew Walkty2, Philippe Rs Lagacé-Wiens1, Heather Adam1, Barbara Swan3, Brenda McAdam3, Peter Pieroni3, Michelle Alfa1, James A Karlowsky1.   

Abstract

INTRODUCTION: Staphylococcus aureus bacteremia is associated with considerable morbidity and mortality. In theory, reducing the turnaround time in reporting of methicillin-resistant S aureus (MRSA) among patients with bactermia could assist with the rapid optimization of antimicrobial therapy.
OBJECTIVE: To evaluate the sensitivity and specificity of MRSASelect (Bio-Rad Laboratories, USA), a chromogenic medium, in the early detection of MRSA from blood cultures growing Gram-positive cocci in clusters, and to confirm that routine use of this medium would, in fact, reduce turnaround time for MRSA identification.
METHODS: The present study was conducted at three microbiology laboratories in Manitoba. Between April 2010 and May 2011, positive blood cultures with Gram-positive cocci in clusters visualized on Gram stain were subcultured to both MRSASelect and routine media. MRSA isolates were identified using conventional microbiological methods from routine media and using growth with the typical colony morphology (pink colony) on MRSASelect medium.
RESULTS: A total of 490 blood cultures demonstrating Gram-positive cocci in clusters on Gram stain were evaluated. S aureus was recovered from 274 blood cultures, with 51 S aureus isolates (51 of 274 [18.6%]) identified as MRSA. MRSASelect medium had a sensitivity of 98%, a specificity of 100%, a positive predictive value of 100% and a negative predictive value of 99.8% for the recovery and identification of MRSA directly from positive blood culture bottles. In addition, use of MRSASelect medium was found to improve turnaround time in the detection of MRSA by almost 24 h relative to conventional methods. DISCUSSION: These data support the utility of MRSASelect medium for the rapid identification of MRSA from positive blood cultures. Further clinical studies are warranted to determine whether the improvement in turnaround time will result in a measurable reduction in suboptimal antimicrobial therapy and/or improvement in patient outcome.

Entities:  

Keywords:  Blood cultures; Chromogenic agar; MRSA; Staphylococcus aureus

Year:  2013        PMID: 24489570      PMCID: PMC3905011          DOI: 10.1155/2013/201516

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


  22 in total

1.  Clinical impact of a real-time PCR assay for rapid identification of staphylococcal bacteremia.

Authors:  Abigail M Frye; Catherine A Baker; D Leif Rustvold; Kim A Heath; Jessica Hunt; James E Leggett; Margret Oethinger
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

2.  Alternative use for spectra MRSA chromogenic agar in detection of methicillin-resistant Staphylococcus aureus from positive blood cultures.

Authors:  Jess F Peterson; Alexander A Dionisio; Katherine M Riebe; Gerri S Hall; Deborah A Wilson; Susan Whittier; Joseph R Dipersio; Nathan A Ledeboer
Journal:  J Clin Microbiol       Date:  2010-04-14       Impact factor: 5.948

3.  Use of BBL CHROMagar MRSA medium for identification of methicillin-resistant Staphylococcus aureus directly from blood cultures.

Authors:  John Pape; Jill Wadlin; Irving Nachamkin
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

4.  An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia.

Authors:  Karri A Bauer; Jessica E West; Joan-Miquel Balada-Llasat; Preeti Pancholi; Kurt B Stevenson; Debra A Goff
Journal:  Clin Infect Dis       Date:  2010-11-01       Impact factor: 9.079

5.  Prevalence of antimicrobial resistant pathogens from blood cultures from Canadian hospitals: results of the CANWARD 2007-2009 study.

Authors:  Heather J Adam; Melanie DeCorby; Robert Rennie; James A Karlowsky; Daryl J Hoban; George G Zhanel
Journal:  Diagn Microbiol Infect Dis       Date:  2011-03       Impact factor: 2.803

6.  Evaluation of Bio-Rad MRSASelect agar for detection of methicillin-resistant Staphylococcus aureus directly from blood cultures.

Authors:  Stefan Riedel; Lisa Dam; Paul D Stamper; Syed A R Shah; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2010-04-14       Impact factor: 5.948

Review 7.  Clinical management of Staphylococcus aureus bacteraemia.

Authors:  Guy E Thwaites; Jonathan D Edgeworth; Effrossyni Gkrania-Klotsas; Andrew Kirby; Robert Tilley; M Estée Török; Sarah Walker; Heiman Fl Wertheim; Peter Wilson; Martin J Llewelyn
Journal:  Lancet Infect Dis       Date:  2011-03       Impact factor: 25.071

Review 8.  Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia.

Authors:  Mical Paul; Galia Kariv; Elad Goldberg; Maria Raskin; Hila Shaked; Rawi Hazzan; Zmira Samra; Dina Paghis; Jihad Bishara; Leonard Leibovici
Journal:  J Antimicrob Chemother       Date:  2010-10-14       Impact factor: 5.790

9.  Community-associated versus healthcare-associated methicillin-resistant Staphylococcus aureus bacteraemia: a 10-year retrospective review.

Authors:  J O Robinson; J C Pearson; K J Christiansen; G W Coombs; R J Murray
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-10-11       Impact factor: 3.267

10.  Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia.

Authors:  Sung-Han Kim; Wan-Beom Park; Ki-Deok Lee; Cheol-In Kang; Ji-Whan Bang; Hong-Bin Kim; Eui-Chong Kim; Myoung-don Oh; Kang-Won Choe
Journal:  J Antimicrob Chemother       Date:  2004-07-14       Impact factor: 5.790

View more
  2 in total

1.  Screening agars for MRSA: evaluation of a stepwise diagnostic approach with two different selective agars for the screening for methicillin-resistant Staphylococcus aureus (MRSA).

Authors:  Volker Micheel; Benedikt Hogan; Thomas Köller; Philipp Warnke; Sabine Crusius; Rebecca Hinz; Ralf Matthias Hagen; Norbert Georg Schwarz; Hagen Frickmann
Journal:  Mil Med Res       Date:  2015-07-21

2.  Multicenter Evaluation of MRSASelect II Chromogenic Agar for Identification of Methicillin-Resistant Staphylococcus aureus from Wound and Nasal Specimens.

Authors:  Diana R Hernandez; Duane W Newton; Nathan A Ledeboer; Blake Buchan; Carol Young; Andrew E Clark; Jessica Connoly; Donna M Wolk
Journal:  J Clin Microbiol       Date:  2015-11-18       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.